Mikhail Naum Kosiborod (Mikhail N Kosiborod, Mikhail Kosiborod)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 70

Top Topics

Ejection Fraction

Aortic Stenosis

Top Venues

Nature medicine

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Safia Chatur, Muthiah Vaduganathan, Brian Lee Claggett, Jonathan W Cunningham, Kieran F Docherty, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, Adrian F Hernandez, Catherine M Viscoli, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Felipe A Martinez, Sanjiv J Shah, Magnus Petersson, Anna-Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Outpatient Worsening Among Patients With Mildly Reduced and Preserved Ejection Fraction Heart Failure in the DELIVER Trial. Circulation (2023)
Toru Kondo, Karola S Jering, C Jan Willem Borleffs, Rudolf A de Boer, Brian Lee Claggett, Akshay S Desai, Dan Dobreanu, Catherine M Viscoli, Adrian F Hernandez, Stefan P Janssens, Pardeep S Jhund, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Anna Maria Langkilde, Felipe A Martinez, Magnus Petersson, Pham Nguyen Vinh, Muthiah Vaduganathan, Scott D Solomon, John Joseph Valentine McMurray
Patient Characteristics, Outcomes, and Effects of Dapagliflozin According to the Duration of Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Toru Kondo, Jawad Haider Butt, James P Curtain, Pardeep S Jhund, Kieran F Docherty, Brian Lee Claggett, Muthiah Vaduganathan, Erasmus Bachus, Adrian F Hernandez, Carolyn S P Lam, Catherine M Viscoli, Felipe A Martinez, Rudolf A de Boer, Mikhail Naum Kosiborod, Akshay S Desai, Lars Valeur Køber, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, John Joseph Valentine McMurray
Efficacy of Dapagliflozin According to Heart Rate: A Patient-Level Pooled Analysis of DAPA-HF and DELIVER. Circulation. Heart failure (2023)
Gregory D Lewis, Kensey L Gosch, Laura P Cohen, Michael E Nassif, Sheryl L Windsor, Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah, Taiyeb Khumri, Guillermo E Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S Khan, Mikhail Naum Kosiborod, Andrew J Sauer
Effect of Dapagliflozin on 6-Minute Walk Distance in Heart Failure With Preserved Ejection Fraction: PRESERVED-HF. Circulation. Heart failure (2023)
Senthil Selvaraj, Mikhail Naum Kosiborod, Svati H Shah
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation 147 (11) (2023)
John W Ostrominski, Muthiah Vaduganathan, Senthil Selvaraj, Brian Lee Claggett, Zi Michael Miao, Akshay S Desai, Pardeep S Jhund, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Catherine M Viscoli, Felipe A Martinez, Rudolf A de Boer, Adrian F Hernandez, Sanjiv J Shah, Magnus Petersson, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial. Circulation (2023)
Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne, Shushama Alam, Deepak L Bhatt, Christopher P Cannon, Mikhail Naum Kosiborod, null null
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes, obesity & metabolism (2023)
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Scott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, Alexander Peikert, Orly Vardeny, Mikhail Naum Kosiborod, Jeffrey S Berger, Harmony R Reynolds, Stephanie Mavromichalis, Anya Barytol, Andrew D Althouse, James F Luther, Eric S Leifer, Andrei L Kindzelski, Andrea N Edginton, Michelle Ng Gong, Lucy Z Kornblith, Pooja Khatri, Keri S Kim, Lisa Baumann Kreuziger, Lana Wahid, Bridget-Anne Kirwan, Mark W Geraci, Matthew D Neal, Judith S Hochman, null null
Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial. Circulation (2023)
Suzanne V Arnold, James A de Lemos, Luke Zheng, Robert S Rosenson, Christie M Ballantyne, Shushama Alam, Deepak L Bhatt, Christopher P Cannon, Mikhail Naum Kosiborod, null null
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study. Diabetes, obesity & metabolism (2023)
Barry A Borlaug, Dalane W Kitzman, Melanie J Davies, Søren Rasmussen, Eric Barros, Javed Butler, Mette Nygaard Einfeldt, G Kees Hovingh, Daniél Vega Møller, Mark C Petrie, Sanjiv J Shah, Subodh Verma, Walter Abhayaratna, Fozia Z Ahmed, Vijay Chopra, Justin A Ezekowitz, Michael Fu, Hiroshi Ito, Małgorzata Lelonek, Vojtech Melenovsky, Julio Nunez, Eduardo R Perna, Morten Schou, Michele Senni, Peter Van der Meer, Dirk von Lewinski, Dennis Wolf, Mikhail Naum Kosiborod
Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial. Nature medicine (2023)
Ildiko Lingvay, Vanita R Aroda, Julie Broe Honoré, Anne S Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod
Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014-2019 from a US database: prescriber and patient characteristics. Journal of diabetes 15 (2) (2023)
Michael E Nassif, Sheryl L Windsor, Kensey L Gosch, Barry A Borlaug, Mansoor Husain, Catherine M Viscoli, Dalane W Kitzman, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Sanjiv J Shah, Guillermo Umpierrez, Bethany A Austin, Sumant Lamba, Taiyeb Khumri, Kavita Sharma, Mikhail Naum Kosiborod
Dapagliflozin Improves Heart Failure Symptoms and Physical Limitations Across the Full Range of Ejection Fraction: Pooled Patient-Level Analysis From DEFINE-HF and PRESERVED-HF Trials. Circulation. Heart failure (2023)
Senthil Selvaraj, Mikhail Naum Kosiborod, Svati H Shah
Response by Selvaraj et al to Letter Regarding Article, "Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF". Circulation 147 (11) (2023)
Su Ern Yeoh, Kieran F Docherty, Ross T Campbell, Pardeep S Jhund, Ann Hammarstedt, Hiddo J Lambers Heerspink, Petr Jarolim, Lars Valeur Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Piotr Ponikowski, Scott D Solomon, Mikaela Sjöstrand, Olof F Bengtsson, Peter J Greasley, Naveed Sattar, Paul I Welsh, Marc S Sabatine, David A Morrow, John Joseph Valentine McMurray
Endothelin-1, Outcomes in Patients With Heart Failure and Reduced Ejection Fraction, and Effects of Dapagliflozin: Findings From DAPA-HF. Circulation (2023)
Mikhail Naum Kosiborod, Subodh Verma, Barry A Borlaug, Javed Butler, Melanie J Davies, Thomas Jon Jensen, Søren Rasmussen, Peter Erlang Marstrand, Mark Colquhoun Petrie, Sanjiv J Shah, Hiroshi Ito, Morten Schou, Vojtech Melenovsky, Walter Abhayaratna, Dalane W Kitzman
Effects of Semaglutide on Symptoms, Function, and Quality of Life in Patients with Heart Failure with Preserved Ejection Fraction and Obesity: A Prespecified Analysis of the STEP-HFpEF Trial. Circulation (2023)
Kashvi Gupta, John A Spertus, Mary Birmingham, Kensey L Gosch, Mansoor Husain, Dalane W Kitzman, Bertram Pitt, Sanjiv J Shah, James L Januzzi, Ildiko Lingvay, Javed Butler, Mikhail Naum Kosiborod, David E Lanfear
Racial Differences in Quality of Life in Patients With Heart Failure Treated With Sodium-Glucose Cotransporter 2 Inhibitors: A Patient-Level Meta-Analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF Trials. Circulation (2023)
John Joseph Valentine McMurray, Kieran F Docherty, Rudolf A de Boer, Ann Hammarstedt, Dalane W Kitzman, Mikhail Naum Kosiborod, Anna Maria Langkilde, Barry Reicher, Michele Senni, Sanjiv J Shah, Ulrica Wilderäng, Subodh Verma, Scott D Solomon
Effect of Dapagliflozin Versus Placebo on Symptoms and 6-Minute Walk Distance in Patients With Heart Failure: The DETERMINE Randomized Clinical Trials. Circulation (2023)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2023)
Kamlesh Khunti F MedSci, Yuehuan Chung, Jim Davies, Benjamin C T Field, Sophie Harris, Mikhail Naum Kosiborod, Dinesh Nagi, Parth Narendran, Dipesh Patel, Robert E J Ryder, Kinga A Várnai, Sarah D Wild, Emma G Wilmot, Rustam D Rea, null null
Association Between SGLT2 Inhibitor Treatment and Diabetic Ketoacidosis and Mortality in People With Type 2 Diabetes Admitted to Hospital With COVID-19. Diabetes care (2022)
Carly Adamson, Kieran F Docherty, Hiddo J Lambers Heerspink, Rudolf A de Boer, Kevin Damman, Catherine M Viscoli, Lars Valeur Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Mark Colquhoun Petrie, Piotr Ponikowski, Marc S Sabatine, Morten Schou, Scott D Solomon, Subodh Verma, Olof F Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Muthiah Vaduganathan, Pardeep S Jhund, John Joseph Valentine McMurray
Initial Decline (Dip) in Estimated Glomerular Filtration Rate After Initiation of Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction: Insights From DAPA-HF. Circulation 146 (6) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kieran F Docherty, Paul I Welsh, Subodh Verma, Rudolf A de Boer, Eileen O'Meara, Olof F Bengtsson, Lars Valeur Køber, Mikhail Naum Kosiborod, Ann Hammarstedt, Anna Maria Langkilde, Daniel Lindholm, Dustin J Little, Mikaela Sjöstrand, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, David A Morrow, Morten Schou, Scott D Solomon, Naveed Sattar, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF. Circulation 146 (13) (2022)
Alexander Peikert, Felipe A Martinez, Muthiah Vaduganathan, Brian Lee Claggett, Ian J Kulac, Akshay S Desai, Pardeep S Jhund, Rudolf A de Boer, David L DeMets, Adrian F Hernandez, Catherine M Viscoli, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Sanjiv J Shah, Tsvetana Katova, Béla Merkely, Orly Vardeny, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial. Circulation. Heart failure 15 (10) (2022)
Adriaan A Voors, Christiane E Angermann, John R Teerlink, Sean P Collins, Mikhail Naum Kosiborod, Jan Biegus, João Pedro Ferreira, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, C Jan Willem Borleffs, Changsheng Ma, Joseph Comin-Colet, Michael Fu, Stefan P Janssens, Robert G Kiss, Robert J Mentz, Yasushi Sakata, Henrik Schirmer, Morten Schou, P Christian Schulze, Lenka Spinarova, Maurizio Volterrani, Jerzy Krzysztof Wranicz, Uwe Zeymer, Shelley Zieroth, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Piotr Ponikowski
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nature medicine 28 (3) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Xiaowen Wang, Muthiah Vaduganathan, Brian Lee Claggett, Sheila M Hegde, Maria Pabon, Ian J Kulac, Orly Vardeny, Eileen O'Meara, Shelley Zieroth, Tzvetana Katova, Martina M McGrath, Anne-Catherine Pouleur, Pardeep S Jhund, Akshay S Desai, Catherine M Viscoli, Mikhail Naum Kosiborod, Rudolf A de Boer, Lars Valeur Køber, Marc S Sabatine, Felipe A Martinez, Piotr Ponikowski, Sanjiv J Shah, Adrian F Hernandez, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon, Carolyn Su Ping Lam
Sex Differences in Characteristics, Outcomes and Treatment Response with Dapagliflozin across the Range of Ejection Fraction in Patients with Heart Failure: Insights from DAPA-HF and DELIVER. Circulation (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Mikhail Naum Kosiborod, Christiane E Angermann, Sean P Collins, John R Teerlink, Piotr Ponikowski, Jan Biegus, Josep Comín Colet, Joao Pedro Ferreira, Robert J Mentz, Michael E Nassif, Mitchell A Psotka, Jasper Tromp, Martina Brueckmann, Jonathan P Blatchford, Afshin Salsali, Adriaan A Voors
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial. Circulation 146 (4) (2022)
Jawad H Butt, Pardeep S Jhund, Jan Belohlávek, Rudolf A de Boer, Chern-En Chiang, Akshay S Desai, Jarosław Drożdż, Adrian F Hernandez, Catherine M Viscoli, Tzvetana Katova, Masafumi Kitakaze, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, Anna Maria Langkilde, Daniel Lindholm, Erasmus Bachus, Felipe A Martinez, Bela Merkely, Magnus Petersson, Jose F Kerr Saraiva, Sanjiv J Shah, Muthiah Vaduganathan, Orly Vardeny, Ulrica Wilderäng, Brian Lee Claggett, Scott D Solomon, John Joseph Valentine McMurray
Efficacy and Safety of Dapagliflozin According to Frailty in Patients With Heart Failure: A Prespecified Analysis of the DELIVER Trial. Circulation 146 (16) (2022)
Senthil Selvaraj, Zhuxuan Fu, Philip G Jones, Lydia Coulter Kwee, Sheryl L Windsor, Olga R Ilkayeva, Christopher B Newgard, Kenneth B Margulies, Mansoor Husain, Catherine M Viscoli, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, David E Lanfear, Michael E Nassif, Ali Javaheri, Robert J Mentz, Mikhail Naum Kosiborod, Svati H Shah, null null
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF. Circulation 146 (11) (2022)
Mikhail Naum Kosiborod, Meena Bhatta, Melanie Jane Davies, John E Deanfield, W Timothy Garvey, Usman Khalid, Robert Kushner, Domenica M Rubino, Niels Zeuthen, Subodh Verma
Semaglutide improves cardiometabolic risk factors in adults with overweight or obesity: STEP 1 and 4 exploratory analyses. Diabetes, obesity & metabolism (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kim A Connelly, C David Mazer, Pankaj Puar, Hwee Teoh, Chao-Hung Wang, Tamique Mason, Farhad Akhavein, Ching-Wen Chang, Min-Hui Liu, Ning-I Yang, Wei-Siang Chen, Yu-Hsiang Juan, Erika Opingari, Yaseen Salyani, William Barbour, Aryan Pasricha, Shamon Ahmed, Andrew Kosmopoulos, Raj Verma, Michael Moroney, Ehab Bakbak, Aishwarya Krishnaraj, Deepak L Bhatt, Javed Butler, Mikhail Naum Kosiborod, Carolyn Su Ping Lam, David A Hess, Otávio Rizzi Coelho-Filho, Myriam Lafreniere-Roula, Kevin E Thorpe, Adrian Quan, Lawrence Alan Leiter, Andrew T Yan, Subodh Verma
Empagliflozin and Left Ventricular Remodeling in People Without Diabetes: Primary Results of the EMPA-HEART 2 CardioLink-7 Randomized Clinical Trial. Circulation (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Suping Ling, Francesco Zaccardi, Bogdan Vlacho, Ping Li, Jordi Real Gatius, Manel Mata-Cases, Josep Franch-Nadal, Mikhail Naum Kosiborod, Clare Gillies, Peter Fenici, Esmeralda Castelblanco, Baiju R Shah, Kamlesh Khunti F MedSci
All-cause and cardiorenal mortality in 6 million adults with and without type 2 diabetes: A comparative, trend analysis in Canada, Spain, and the UK. Diabetes, obesity & metabolism (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Kamlesh Khunti F MedSci, Vanita R Aroda, Deepak L Bhatt, Biykem Bozkurt, John B Buse, Hiddo J Lambers Heerspink, Catherine M Viscoli, Carolyn Su Ping Lam, Nikolaus Marx, John Joseph Valentine McMurray, Scott D Solomon, Mikhail Naum Kosiborod
Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence. Diabetes, obesity & metabolism 24 (11) (2022)
John A Spertus, Mary C Birmingham, Michael Nassif, C V Damaraju, Antonio Abbate, Javed Butler, David E Lanfear, Ildiko Lingvay, Mikhail Naum Kosiborod, James L Januzzi
The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial. Nature medicine 28 (4) (2022)
Pardeep S Jhund, Toru Kondo, Jawad Haider Butt, Kieran F Docherty, Brian L Claggett, Akshay S Desai, Muthiah Vaduganathan, Samvel B Gasparyan, Olof F Bengtsson, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, Rudolf A de Boer, David DeMets, Adrian F Hernandez, Silvio E Inzucchi, Mikhail Naum Kosiborod, Lars Valeur Køber, Carolyn Su Ping Lam, Felipe A Martinez, Marc S Sabatine, Sanjiv J Shah, Scott D Solomon, John Joseph Valentine McMurray
Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER. Nature medicine 28 (9) (2022)
Orly Vardeny, James C Fang, Akshay S Desai, Pardeep S Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A de Boer, Adrian F Hernandez, Carolyn Su Ping Lam, Silvio E Inzucchi, Felipe A Martinez, Mikhail Naum Kosiborod, David DeMets, Eileen O'Meara, Shelley Zieroth, Josep Comín Colet, Jarosław Drożdż, Chern-En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John Joseph Valentine McMurray, Scott D Solomon
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial. Nature medicine 28 (12) (2022)
Ewa Anita Jankowska, Bridget-Anne Kirwan, Mikhail Naum Kosiborod, Javed Butler, Stefan D Anker, Theresa McDonagh, Maria Dorobantu, Jarosław Drożdż, Gerasimos S Filippatos, Andre Keren, Irakli Khintibidze, Hans Kragten, Felipe A Martinez, Marco Metra, Davor Milicic, Jose Carlos Nicolau, Marcus Ohlsson, Alexander Parkhomenko, Domingo Pascual Figal, Frank Ruschitzka, David Sim, Hadi Skouri, Peter van der Meer, Basil S Lewis, Josep Comín Colet, Stephan von Haehling, Alain Cohen-Solal, Tabassome Simon, Wolfram Doehner, Henry J Dargie, Michael Motro, Tim Friede, Vincent Fabien, Fabio Dorigotti, Stuart J Pocock, Piotr Ponikowski
The effect of intravenous ferric carboxymaltose on health-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal (2021)
Michael E Nassif, John A Spertus, Fengming Tang, Sheryl L Windsor, Philip G Jones, Merrill Thomas, Yevgeniy Khariton, John Brush, Robert A Gordon, Rita Jermyn, Orvar Jonsson, Sumant Lamba, David M Shavelle, Mikhail Naum Kosiborod
Association Between Change in Ambulatory Hemodynamic Pressures and Symptoms of Heart Failure. Circulation. Heart failure 14 (11) (2021)
Michael E Nassif, Sheryl L Windsor, Barry A Borlaug, Dalane W Kitzman, Sanjiv J Shah, Fengming Tang, Yevgeniy Khariton, Ali O Malik, Taiyeb Khumri, Guillermo Umpierrez, Sumant Lamba, Kavita Sharma, Sadiya S Khan, Lokesh Chandra, Robert A Gordon, John J Ryan, Sunit-Preet Chaudhry, Susan M Joseph, Chen H Chow, Manreet K Kanwar, Michael Pursley, Elias S Siraj, Gregory D Lewis, Barry S Clemson, Michael W Fong, Mikhail Naum Kosiborod
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial. Nature medicine 27 (11) (2021)
David D Berg, Kieran F Docherty, Naveed Sattar, Petr Jarolim, Paul I Welsh, Pardeep S Jhund, Inder S Anand, Vijay K Chopra, Rudolf A de Boer, Mikhail Naum Kosiborod, Jose Carlos Nicolau, Eileen O'Meara, Morten Schou, Ann Hammarstedt, Anna-Maria Langkilde, Daniel Lindholm, Mikaela Sjöstrand, John Joseph Valentine McMurray, Marc S Sabatine, David A Morrow
Serial Assessment of High-Sensitivity Cardiac Troponin and the Effect of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: An Analysis of the DAPA-HF Trial. Circulation (2021)
Nitchakarn Laichuthai, Muhammad Abdul-Ghani, Mikhail Naum Kosiborod, Wasita Warachit Parksook, Stephen J Kerr, Ralph A De Fronzo
Newly Discovered Abnormal Glucose Tolerance in Patients With Acute Myocardial Infarction and Cardiovascular Outcomes: A Meta-analysis. Diabetes care 43 (8) (2021)
Rose A Gubitosi-Klug, Xiaoyu Gao, Pradipta R Ray, Ian H de Boer, Neill White, Lloyd P Aiello, Ryan Miller, Jerry Palmer, William Tamborlane, Amisha Wallia, Mikhail Naum Kosiborod, John M Lachin, Ionut Bebu, null null
Associations of Microvascular Complications With the Risk of Cardiovascular Disease in Type 1 Diabetes. Diabetes care 44 (7) (2021)
Michael E Nassif, Sheryl L Windsor, Fengming Tang, Mansoor Husain, Catherine M Viscoli, Darren K McGuire, Bertram Pitt, Benjamin M Scirica, Bethany Austin, Michael W Fong, Shane J LaRue, Guillermo E Umpierrez, Justin Hartupee, Yevgeniy Khariton, Ali O Malik, Modele O Ogunniyi, Nanette K Wenger, Mikhail Naum Kosiborod
Dapagliflozin effects on lung fluid volumes in patients with heart failure and reduced ejection fraction: Results from the DEFINE-HF trial. Diabetes, obesity & metabolism 23 (6) (2021)
Merrill Thomas, Melissa Magwire, Kensey L Gosch, Yasser Sammour, Rane Mehta, James O'Keefe, Michael E Nassif, Mikhail Naum Kosiborod
Cardiometabolic Center of Excellence: A Novel Care Delivery Model for Secondary Prevention of Cardiovascular Disease in Type 2 Diabetes. Circulation. Cardiovascular quality and outcomes 14 (10) (2021)
Mikhail Naum Kosiborod, Otavio Berwanger, Gary G Koch, Felipe Martinez, Omar Mukhtar, Subodh Verma, Vijay Chopra, Ali Javaheri, Philip Ambery, Samvel B Gasparyan, Joan Buenconsejo, C David Sjöström, Anna Maria Langkilde, Jan Oscarsson, Russell Esterline
Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study. Diabetes, obesity & metabolism 23 (4) (2021)
Catherine M Viscoli, Kieran F Docherty, Lars Køber, Mikhail Naum Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, Subodh Verma, Jan Bělohlávek, Michael Böhm, Chern-En Chiang, Rudolf A de Boer, Mirta Diez, Andre Dukát, Charlotta E A Ljungman, Olof Bengtsson, Anna Maria Langkilde, Mikaela Sjöstrand, Pardeep S Jhund, John Joseph Valentine McMurray, null null
Dapagliflozin and the Incidence of Type 2 Diabetes in Patients With Heart Failure and Reduced Ejection Fraction: An Exploratory Analysis From DAPA-HF. Diabetes care 44 (2) (2020)
Michael E Nassif, Mikhail Naum Kosiborod
Effects of sodium glucose cotransporter type 2 inhibitors on heart failure. Diabetes, obesity & metabolism (2020)
Eun Sil Koh, Kyungdo Han, You-Seon Nam, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod, Hiddo J Lambers Heerspink, Soon-Jib Yoo, Hyuk-Sang Kwon
Renal outcomes and all-cause death associated with sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL 3 Korea). Diabetes, obesity & metabolism 23 (2) (2020)
Kieran F Docherty, Pardeep S Jhund, Olof Bengtsson, David L DeMets, Catherine M Viscoli, Lars Køber, Mikhail Naum Kosiborod, Anna Maria Langkilde, Felipe A Martinez, Marc S Sabatine, Mikaela Sjöstrand, Scott D Solomon, John Joseph Valentine McMurray, null null
Effect of Dapagliflozin in DAPA-HF According to Background Glucose-Lowering Therapy. Diabetes care 43 (11) (2020)
Krishna K Patel, Marília Brito Gomes, Bernard Charbonnel, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Li-Nong Ji, Kevin F Kennedy, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Stuart J Pocock, Marina V Shestakova, Iichiro Shimomura, Filip Surmont, Hirotaka Watada, Suzanne V Arnold
Global patterns of comprehensive cardiovascular risk factor control in patients with type 2 diabetes mellitus: Insights from the DISCOVER study. Diabetes, obesity & metabolism 23 (1) (2020)
Ionut Bebu, David S Schade, Barbara H Braffett, Mikhail Naum Kosiborod, Maria F Lopes-Virella, Elsayed Z Soliman, William H Herman, David A Bluemke, Amisha Wallia, Trevor Orchard, John M Lachin, null null
Risk Factors for First and Subsequent CVD Events in Type 1 Diabetes: The DCCT/EDIC Study. Diabetes care 43 (4) (2020)
Phil McEwan, Hayley Bennett, Kamlesh Khunti, John P H Wilding, Christopher Edmonds, Marcus Thuresson, Eric T Wittbrodt, Peter Fenici, Mikhail Naum Kosiborod
Assessing the cost-effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus: A comprehensive economic evaluation using clinical trial and real-world evidence. Diabetes, obesity & metabolism 22 (12) (2020)
Eric T Wittbrodt, David Chamberlain, Suzanne V Arnold, Fengming Tang, Mikhail Naum Kosiborod
Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (8) (2019)
Antonio Nicolucci, Bernard Charbonnel, Marília Brito Gomes, Kamlesh Khunti F MedSci, Mikhail Naum Kosiborod, Marina V Shestakova, Iichiro Shimomura, Hirotaka Watada, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Stuart Pocock
Treatment patterns and associated factors in 14 668 people with type 2 diabetes initiating a second-line therapy: Results from the global DISCOVER study programme. Diabetes, obesity & metabolism 21 (11) (2019)
Wenjun Fan, Yang Song, Silvio E Inzucchi, Laurence Sperling, Christopher P Cannon, Suzanne V Arnold, Mikhail Naum Kosiborod, Nathan D Wong
Composite cardiovascular risk factor target achievement and its predictors in US adults with diabetes: The Diabetes Collaborative Registry. Diabetes, obesity & metabolism 21 (5) (2019)
Suzanne V Arnold, Leo Seman, Fengming Tang, Poghni A Peri-Okonny, Keith C Ferdinand, Sanjeev N Mehta, Abhinav Goyal, Laurence S Sperling, Mikhail Naum Kosiborod
Real-world opportunity of empagliflozin to improve blood pressure control in African American patients with type 2 diabetes: A National Cardiovascular Data Registry "research-to-practice" project from the diabetes collaborative registry. Diabetes, obesity & metabolism 21 (2) (2018)
Mikhail Naum Kosiborod, Marilia B Gomes, Antonio Nicolucci, Stuart Pocock, Wolfgang Rathmann, Marina V Shestakova, Hirotaka Watada, Iichiro Shimomura, Hungta Chen, Javier Cid-Ruzafa, Peter Fenici, Niklas Hammar, Filip Surmont, Fengming Tang, Kamlesh Khunti, null null
Vascular complications in patients with type 2 diabetes: prevalence and associated factors in 38 countries (the DISCOVER study program). Cardiovascular diabetology 17 (1) (2018)
Suzanne V Arnold, Jonathan Yap, Carolyn S P Lam, Fengming Tang, Wan T Tay, Tiew H K Teng, Darren K McGuire, James L Januzzi, Gregg C Fonarow, Frederick A Masoudi, Mikhail Naum Kosiborod
Management of patients with diabetes and heart failure with reduced ejection fraction: An international comparison. Diabetes, obesity & metabolism 21 (2) (2018)
Suzanne V Arnold, Mikhail Naum Kosiborod, Jingyan Wang, Peter Fenici, Goran Gannedahl, Robert J LoCasale
Burden of cardio-renal-metabolic conditions in adults with type 2 diabetes within the Diabetes Collaborative Registry. Diabetes, obesity & metabolism 20 (8) (2018)
Marcus Thuresson, Matthew A Cavender, Alex Z Fu, John P Wilding, Kamlesh Khunti F MedSci, Reinhard W Holl, Anna Norhammar, Kåre I Birkeland, Marit Eika Jorgensen, Eric Wittbrodt, Niklas Hammar, Peter Fenici, Mikhail Naum Kosiborod, null null
Comment on Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? Diabetes Care 2018;41:6-10. Diabetes care 41 (6) (2018)